$HIMS is still growing fast Hims & Hers Health reported 38% revenue growth and raised its full-year outlook following the Eucalyptus acquisition, showing the platform can continue adding scale across weight loss, sexual health, dermatology and mental health.
Integration costs, technology investment and international expansion are putting pressure on margins and cash generation, making execution just as important as top-line growth.
The long-term narrative remains aggressive: consensus projects $4.6B in revenue and $241M in earnings by 2029, implying roughly 21.6% annual revenue growth and a swing from a $142M loss today to $241M of profit.
Integration costs, technology investment and international expansion are putting pressure on margins and cash generation, making execution just as important as top-line growth.
The long-term narrative remains aggressive: consensus projects $4.6B in revenue and $241M in earnings by 2029, implying roughly 21.6% annual revenue growth and a swing from a $142M loss today to $241M of profit.